Summit Therapeutics shares rose 23.3% in pre-market trading after AstraZeneca
said it will invest $2.0 billion to take a stake in Summit and to collaborate on
oncology drug development.
2026-09-29
Summit Therapeutics shares rose 23.3% in pre-market trading after AstraZeneca
said it will invest $2.0 billion to take a stake in Summit and to collaborate on
oncology drug development.